CAP accreditation offers several commercial advantages. It facilitates the process of obtaining reimbursement from private insurance providers and enables DiviTum® TKa expansion into New York, Maryland, and Washington D.C. Post license application and approval, Biovica will be able to offer DiviTum also in these locations and thereby be able to cover the entire US. In addition, CAP accreditation is a highly coveted credential, particularly among pharmaceutical and biotechnology companies. They seek it out when they require a more rigorous regulatory framework for their projects, especially when the data generated is intended for submission to the U.S. Food and Drug Administration (FDA).

"I take great pride in the efforts put forth by our team to reach this significant milestone. Attaining CAP accreditation underscores our unwavering commitment to quality.", says Warren Cresswell, President of the Americas at Biovica.

About CAP
The College of American Pathology (CAP) was founded in 1961 in the United States for laboratory quality control and is one of the world's most prestigious accreditation bodies. Through an application process, CAP reviews and accredits laboratories across the United States to ensure these laboratories meet certain safety and patient care criteria, helping laboratories maintain the accuracy of test results, ensuring accurate patient diagnosis, and meeting required standards from CLIA, FDA, and OSHA. CAP accreditation is known as the gold standard for laboratory quality control worldwide and ensures that quality control standards strict enough to conduct testing for clinical diagnostic purposes.